Alexion Pharmaceuticals, Inc. (ALXN) Stock Analysis
DELISTED
What happened to Alexion Pharmaceuticals, Inc. (ALXN) stock?
Alexion Pharmaceuticals, Inc. (ALXN) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 66.36 means the share price is 66.36 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Alexion Pharmaceuticals, Inc. (ALXN). Alexion Pharmaceuticals, Inc. develops and commercializes therapies for rare disorders, focusing on hematology, nephrology, neurology, and metabolic conditions.
Last analyzed: Jun 15, 2026Alexion Pharmaceuticals, Inc. (ALXN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ALXN shares?
No. ALXN stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ALXN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ALXN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Alexion Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.